Cancer- The breaking news on the treatment, cure and diagnosis of cancer

 
 

 
 

  • Search for "cancer news"
  • Threshold drug moves forward on cancer trial but stock falls

    Threshold drug moves forward on cancer trial but stock falls
    Good news from a late-stage cancer study from Threshold Pharmaceuticals Inc. isn't translating into a boon for its stock. The South San Francisco company said Monday that an independent data monitoring committee - a group that recommends halting or moving forward with clinical trials - said Threshold should continue its trial of the drug TH-302 in patients with soft tissue sarcoma.
  • TKC Monday Advice for Kansas City

    TKC Monday Advice for Kansas City
    Possibly the most important article we'll be linking all week . . . File this under, "it's all small stuff" and health news: KCUR: "Chronic stress is hazardous to health and can lead to early death from heart disease, cancer and of other health problems.
  • News from Annals of Internal Medicine tip sheet -- Sept. 23, 2014

    News from Annals of Internal Medicine tip sheet -- Sept. 23, 2014
    The U.S. Preventive Services Task Force recommends intensive behavioral counseling to reduce risky sexual behaviors among all sexually active adolescents and for those adults who are at risk for sexually transmitted infections , according to an evidence-based recommendation being published in Annals of Internal Medicine . Approximately 20 million new cases of STIs occur each year in the United States and half of these cases occur in persons ages 15 to 24 years.
  • E-cigarettes don't help cancer patients quit smoking

    E-cigarettes don't help cancer patients quit smoking
    Smokers with cancer who used e-cigarettes along with traditional cigarettes were more dependent on nicotine than those who didn't use the devices, a Memorial Sloan Kettering study found. These patients were also just as likely -- or less likely -- to have quit smoking than patients who didn't use e-cigarettes.
  • City of Hope Expands Access to Highest-Quality Cancer Care in Communities East of Duarte

    City of Hope Expands Access to Highest-Quality Cancer Care in Communities East of Duarte
    City of Hope and Wilshire Oncology Medical Group have reached an agreement in which Wilshire physicians will join City of Hope Medical Group, delivering care to patients through City of Hope's new community practice sites in Glendora, Pomona, Rancho Cucamonga, West Covina and Corona. "Our community practice sites are set up to expand community access to City of Hope's high-quality care and to offer patients convenient care by City of Hope physicians."
  • Biocompare Cancer
  • Tilted Acoustic Tweezers Separate Cells Gently

    Tilted Acoustic Tweezers Separate Cells Gently
    Precise, gentle and efficient cell separation from a device the size of a cell phone may be possible thanks to tilt-angle standing surface acoustic waves, according to a team of engineers.
  • New Biomarker Highly Promising For Predicting Breast Cancer Outcomes

    New Biomarker Highly Promising For Predicting Breast Cancer Outcomes
    A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research published ahead of print in the journal Molecular and Cellular Biology.
  • Finding Keys To Glioblastoma Therapeutic Resistance

    Finding Keys To Glioblastoma Therapeutic Resistance
    Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy. The answer lies not in the DNA sequence of the tumor, but in its epigenetic signature. These findings have been published online as a priority report in the journal Oncotarget.
  • Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs

    Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs
    A revolutionary new scientific method developed at the University of Leeds will improve the diversity of 'biologically active molecules', such as antibiotics and anti-cancer agents.
  • Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma

    Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma
    CINCINNATI - An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children.